Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

47.73 +0.55 (+1.16%)

Streaming Delayed Price Updated: 11:35 AM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

42 43 Next >

Markets Fears ↗

January 24, 2022

Today markets dropped precipitously over fear of a Ukrainian invasion and higher interest rates and inflation.

Via Talk Markets

FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors ↗

January 24, 2022

The FDA has cleared Lyell Immunopharma Inc's (NASDAQ: LYEL) Investigational New Drug (IND) application to initiate a Phase 1 trial for LYL132 in solid tumors....

Via Benzinga

Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT ↗

January 23, 2022

Trian Fund Management LP, the activist hedge fund run by Nelson Peltz, has built a stake in Unilever PLC (NYSE: UL), the Financial Times reports, citing people with direct...

Via Benzinga

Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows

January 21, 2022

From GSK

Via Business Wire

Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)

January 14, 2022

Via Investor Brand Network

Why Jim Cramer Like NextEra Energy And Lincoln Electric? ↗

January 21, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE:

Via Benzinga

World Markets News ↗

January 20, 2022

Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish.

Via Talk Markets

Wednesday File ↗

January 19, 2022

It sound odd but the real threat to markets is slowing Chinese growth which fell to 4% in Q4 from double that earlier last year.

Via Talk Markets

Chopped Stocks ↗

January 18, 2022

The day's theme is sell tech and buy banks.

Via Talk Markets

23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock? ↗

January 18, 2022

Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began...

Via Benzinga

GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit ↗

January 15, 2022

GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business. The U.K. pharma giant says the business is well-positioned to...

Via Benzinga

More Serious Matters ↗

January 14, 2022

Wall Street fell on new worries about inflation and a drop in retail sales levels.

Via Talk Markets

Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK) ↗

January 14, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Shares of GlaxoSmithKline PLC (NYSE: GSK...

Via Benzinga

WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge ↗

January 14, 2022

An expert panel at the World Health Organization (WHO) recommended the use of treatments developed by Eli Lilly And Co (NYSE: LLY) and GlaxoSmithKline Plc...

Via Benzinga

Two Curses Of The Current Year ↗

January 13, 2022

The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%.

Via Talk Markets

GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19 ↗

January 13, 2022

GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have applied to the FDA to include intramuscular (IM) administration to sotrovimab...

Via Benzinga

Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies ↗

January 13, 2022

Adagio Therapeutics Inc (NASDAQ: ADGI) shares gain during the premarket session after recent findings showing that ADG20 has neutralization activity against the omicron...

Via Benzinga

US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy ↗

January 11, 2022

The U.S. has agreed to buy 600,000 more doses of GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 antibody...

Via Benzinga

CureVac Outlines Upcoming Catalysts For Vaccine Programs ↗

January 10, 2022

Ahead of J.P. Morgan Healthcare Conference, CureVac BV (NASDAQ: CVAC) outlined the timeline for its vaccine programs. CureVac's preclinical second-...

Via Benzinga

Market Briefing For Wednesday, Jan. 5 ↗

January 05, 2022

Rising interest rates have yet to spark overt action by the Fed nor yet to cool-off the hot real estate market. However, the Nasdaq was hit hard, presumably as the 10-year rallied.

Via Talk Markets

Market Trend: Erratic And Unreliable ↗

December 29, 2021

Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is.

Via Talk Markets

Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant ↗

December 29, 2021

Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The...

Via Benzinga

Pfizer's CEO Shows You How To Get 'Impossible' Tasks Done Fast ↗

December 29, 2021

Scientists told the Pfizer CEO they could create a vaccine in 18 months. But Albert Bourla knew they could work even faster.

Via Investor's Business Daily

A Bit Of Good News ↗

December 22, 2021

US growth figures for Q3 were up from forecasts of 2.1% at 2.3% but well down from the prior quarter level of 6.7%.

Via Talk Markets

GSK Option Bulls Get Head Start on Cup & Handle ↗

December 21, 2021

Pharma has been one of the best performing industries in recent weeks and GlaxoSmithKline has been among the top performers. Today, it appears that call buyers are stepping into the stock as it tests...

Via Talk Markets

The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail ↗

December 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ADC In Lung And Head & Neck Cancer Patients...

Via Benzinga

Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option ↗

December 21, 2021

The FDA has approved ViiV Healthcare's Apretude, the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option, to reduce the risk of...

Via Benzinga

Dreaming Of A Red Christmas ↗

December 20, 2021

The stock market is reacting with lots of selling to the weekend's news.

Via Talk Markets

7 Stocks to Buy if Covid-19 Becomes Endemic ↗

December 20, 2021

Watching the developments of the Covid-19 crisis, it could become endemic. Here’s what that means for certain stocks to buy.

Via InvestorPlace

GlaxoSmithKline: Investing In Vaccines ↗

December 19, 2021

GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture, and marketing of pharmaceutical and consumer healthcare products. Let's take a look...

Via Talk Markets

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Starting at $3.75/week.

Subscribe Today